Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension

Cork, M.J. orcid.org/0000-0003-4428-2428, Thaçi, D., Eichenfield, L.F. et al. (19 more authors) (2019) Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis : results from a phase IIa open‐label trial and subsequent phase III open‐label extension. British Journal of Dermatology. 18476. ISSN 0007-0963

Abstract

Metadata

Authors/Creators:
  • Cork, M.J. ORCID logo https://orcid.org/0000-0003-4428-2428
  • Thaçi, D.
  • Eichenfield, L.F.
  • Arkwright, P.D.
  • Hultsch, T.
  • Davis, J.D.
  • Zhang, Y.
  • Zhu, X.
  • Chen, Z.
  • Li, M.
  • Ardeleanu, M.
  • Teper, A.
  • Akinlade, B.
  • Gadkari, A.
  • Eckert, L.
  • Kamal, M.A.
  • Ruddy, M.
  • Graham, N.M.H.
  • Pirozzi, G.
  • Stahl, N.
  • DiCioccio, A.T.
  • Bansal, A.
Copyright, Publisher and Additional Information: © 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Dates:
  • Accepted: 31 August 2019
  • Published (online): 8 October 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 04 Nov 2019 09:37
Last Modified: 04 Nov 2019 09:37
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/bjd.18476

Share / Export

Statistics